National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2022 (No. 2) (Cth)

PB 35 of 2022

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2022 (No. 2)

National Health Act 1953

___________________________________________________________________________

I, CAROLINE TURNOUR, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Instrument under paragraph 98C(1) of the National Health Act 1953.

Dated                             28 April 2022

CAROLINE TURNOUR

Assistant Secretary (Acting)

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

Contents

1.......... Name............................................................................................................................................ 1

2.......... Commencement............................................................................................................................ 1

3.......... Authority...................................................................................................................................... 1

4.......... Schedules..................................................................................................................................... 1

Schedule 1—Amendments   2

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 Error! Bookmark not defined.

1. Name

(1)This Instrument is the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2022 (No. 2).

(2)This Instrument may also be cited as PB 35 of 2022.

1. Commencement

(1)Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1.  The whole of this instrument	1 May 2022	1 May 2022

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

1. Authority

This instrument is made under paragraph 98C(1) of the National Health Act 1953.

4     Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (PB 114 of 2019)

1. Schedule 4, entry for Desmopressin

omit:

Desmopressin Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 50 actuations, 5 mL

1. Schedule 4, after entry for Nicorandil in the form Tablets 20 mg, 60

insert:

Onasemnogene abeparvovec	Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 3 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 4 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 5 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 6 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 7 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 8 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 3 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 4 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 5 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 6 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 7 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 3 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 4 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 5 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 6 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 7 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 8 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL
Onasemnogene abeparvovec	Pack containing 9 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL